Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07636161 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

Name: PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon) — clinical trial record (NCT07636161)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusSuspended

PhasePhase 4

SponsorUniversity of Miami

Started2026-10

View on ClinicalTrials.gov ↗

Why the trial stopped

The sponsor has communicated that they may no longer fund this research study. Pending final confirmation if the study will be closed.

Amendment history

2026-09-29

Trial status changed: Not Yet Recruiting → Suspended

Recruitment suspended: The sponsor has communicated that they may no longer fund this research study. Pending final confirmation if the s...

University of Miami

241 trials monitored

See 29 trials at risk

Diabetes

4,247 trials monitored

See 176 trials at risk

Type 2 Diabetes

2,082 trials monitored

See 101 trials at risk

The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.

Trial Details

NCT Number	NCT07636161
Lead Sponsor	University of Miami Collaborators: Sexual Medicine Society of North America Inc.
Conditions	Type 2 Diabetes, Type 2 Diabetes (T2DM)
Enrollment	30 participants
Start Date	2026-10
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-09-28